Insulet Corporation (PODD) Stock Forecast
PODD analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 26 analysts
- Price target
- $167.17 average of analyst targets
- Upside to target
- +18.5% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $1.59
- 52-week range
- $130.47 – $346.36
PODD analyst ratings
26 analystsNumber of analysts at each rating.
PODD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PODD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.59 | $1.50 | $1.66 | $1.24 | +28.0% | 23 |
| Current fiscal year (2026) | $6.51 | $6.41 | $6.61 | $4.97 | +30.9% | 24 |
| Next fiscal year (2027) | $7.72 | $7.26 | $8.35 | $6.51 | +18.7% | 24 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PODD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $832.6M | $826.3M | $838.1M | +17.9% | 23 |
| Current fiscal year (2026) | $3.29B | $3.19B | $3.30B | +21.4% | 25 |
| Next fiscal year (2027) | $3.73B | $3.44B | $3.83B | +13.6% | 25 |
PODD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PODD revenue: reported and forecast
PODD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.64 | $1.59 | $1.59 | $1.59 | $1.59 | −3.0% | 1 up · 1 down |
| Current fiscal year (2026) | $6.48 | $6.50 | $6.50 | $6.50 | $6.51 | +0.5% | 2 up · 1 down |
| Next fiscal year (2027) | $8.06 | $7.72 | $7.71 | $7.72 | $7.72 | −4.1% | 1 up · 3 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PODD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PODD beat in 11 of 12.
What analysts expect from PODD
26 analysts cover Insulet; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $167.17, 18.5% above the latest close of $141.10. Analysts expect earnings of $6.51 per share for 2026, +30.9% from a year earlier. For 2027 the average estimate is $7.72 per share on revenue of $3.7 billion. Insulet beat the EPS estimate in 11 of the last 12 quarters.
Related: PODD income statement, PODD key metrics, PODD chart. See the PODD stock overview for the latest quote and news.
PODD forecast FAQ
What is Insulet's price target?
The average analyst price target for Insulet is $167.17, 18.5% above the latest close of $141.10.
Is Insulet a buy, hold or sell?
Of 26 analysts covering Insulet, 11 rate it a strong buy, 4 a buy, 11 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Insulet's EPS forecast?
Analysts forecast $6.51 per share for 2026 (range $6.41 to $6.61); for 2027 the estimate is $7.72.
What is Insulet's revenue forecast?
The average revenue estimate for 2026 is $3.3 billion, growth of 21.4%; for 2027 it is $3.7 billion.
When does Insulet report earnings?
Insulet is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $1.59.
Does Insulet usually beat earnings estimates?
Insulet reported EPS at or above the analyst estimate in 11 of the last 12 quarters.